GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (GREY:BNZPF) » Definitions » Equity-to-Asset

Biosenic (Biosenic) Equity-to-Asset : -1.62 (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biosenic Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biosenic's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-18.29 Mil. Biosenic's Total Assets for the quarter that ended in Jun. 2023 was $11.26 Mil.

The historical rank and industry rank for Biosenic's Equity-to-Asset or its related term are showing as below:

BNZPF' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.3   Med: 0.12   Max: 0.68
Current: -1.63

During the past 10 years, the highest Equity to Asset Ratio of Biosenic was 0.68. The lowest was -2.30. And the median was 0.12.

BNZPF's Equity-to-Asset is ranked worse than
93.8% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs BNZPF: -1.63

Biosenic Equity-to-Asset Historical Data

The historical data trend for Biosenic's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Equity-to-Asset Chart

Biosenic Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.09 0.13 -2.30 0.12

Biosenic Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -2.30 -0.85 0.12 -1.62

Competitive Comparison of Biosenic's Equity-to-Asset

For the Biotechnology subindustry, Biosenic's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosenic's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biosenic's Equity-to-Asset falls into.



Biosenic Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biosenic's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=3.735/31.064
=

Biosenic's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )=Total Stockholders Equity/Total Assets
=-18.29/11.259
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosenic  (GREY:BNZPF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Biosenic Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biosenic's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosenic (Biosenic) Business Description

Traded in Other Exchanges
Address
Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic (Biosenic) Headlines

From GuruFocus

Q2 2021 Bone Therapeutics SA Earnings Call Transcript

By GuruFocus Research 03-03-2024